IL10 and Parkinson disease: This study suggests that serum immune biomarker panel, IFNγ, IL-10 and TNFα, may be proposed as a potential state/diagnostic multi-biomarker panel of PD; in addition, IFNγ, IL-10 and NOx may be suggested as a potential ensemble of rate/prognostic biomarkers of PD progression.